HaystackAnalytics develops first Universal Infectious Disease (ID) genomic test : Rashtra News #HaystackAnalytics #develops #Universal #Infectious #Disease #genomic #test Chennai: Healthtech startup HaystackAnalytics on Monday said it has developed India’s first Universal Infectious Disease (ID) genomic test, claiming to make it the world’s first company to bring genomics based infectious diseases diagnostic to hospitals. The […]
At least a quarter of children with cerebral palsy have a clinically important genetic finding and 50 per cent of these will have immediate implications.
Chemo-IO Over IO Alone in Patients With Advanced NSCLC medpagetoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medpagetoday.com Daily Mail and Mail on Sunday newspapers.
is a valuable tool for health care providers to help prescribe the right drug for the right patient to enhance efficacy and avoid side effects.
A new research paper funded in part by the National Heart, Lung and Blood Institute (NHLBI) shows a clear advantage of genetic testing in helping health care providers choose the appropriate anti-platelet drug. Testing helps determine if a patient carries genetic variants in CYP2C19 that cause loss of its function. These variants interfere with the body’s ability to metabolize and activate clopidogrel, an anti-platelet medication.
Anti-platelet drugs are given to prevent complications from blood clotting after a procedure to open clogged arteries. These patients can use one of the various anti-platelet medications, such as clopidogrel, ticagrelor or prasugrel.
Queensland has seven new cases of COVID-19 to report today, bringing the state's total to 1,342. All cases were detected in hotel quarantine. Today's new.